Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis.

Fonseka CY, Rao DA, Teslovich NC, Korsunsky I, Hannes SK, Slowikowski K, Gurish MF, Donlin LT, Lederer JA, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Todd DJ, Bykerk VP, Karlson EW, Ermann J, Lee YC, Brenner MB, Raychaudhuri S.

Sci Transl Med. 2018 Oct 17;10(463). pii: eaaq0305. doi: 10.1126/scitranslmed.aaq0305.

PMID:
30333237
2.

Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis.

Ryzhakov G, West NR, Franchini F, Clare S, Ilott NE, Sansom SN, Bullers SJ, Pearson C, Costain A, Vaughan-Jackson A, Goettel JA, Ermann J, Horwitz BH, Buti L, Lu X, Mukhopadhyay S, Snapper SB, Powrie F.

Nat Commun. 2018 Sep 18;9(1):3797. doi: 10.1038/s41467-018-06085-5.

3.

Author Correction: Towards an arthritis flare-responsive drug delivery system.

Joshi N, Yan J, Levy S, Bhagchandani S, Slaughter KV, Sherman NE, Amirault J, Wang Y, Riegel L, He X, Rui TS, Valic M, Vemula PK, Miranda OR, Levy O, Gravallese EM, Aliprantis AO, Ermann J, Karp JM.

Nat Commun. 2018 May 11;9(1):1954. doi: 10.1038/s41467-018-04346-x.

4.

Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts.

Sun J, Ermann J, Niu N, Yan G, Yang Y, Shi Y, Zou W.

Bone Res. 2018 Apr 26;6:14. doi: 10.1038/s41413-018-0015-x. eCollection 2018.

5.

Towards an arthritis flare-responsive drug delivery system.

Joshi N, Yan J, Levy S, Bhagchandani S, Slaughter KV, Sherman NE, Amirault J, Wang Y, Riegel L, He X, Rui TS, Valic M, Vemula PK, Miranda OR, Levy O, Gravallese EM, Aliprantis AO, Ermann J, Karp JM.

Nat Commun. 2018 Apr 3;9(1):1275. doi: 10.1038/s41467-018-03691-1. Erratum in: Nat Commun. 2018 May 11;9(1):1954.

6.

Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification.

Dey D, Bagarova J, Hatsell SJ, Armstrong KA, Huang L, Ermann J, Vonner AJ, Shen Y, Mohedas AH, Lee A, Eekhoff EM, van Schie A, Demay MB, Keller C, Wagers AJ, Economides AN, Yu PB.

Sci Transl Med. 2016 Nov 23;8(366):366ra163.

PMID:
27881824
7.

IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease.

Urso K, Alvarez D, Cremasco V, Tsang K, Grauel A, Lafyatis R, von Andrian UH, Ermann J, Aliprantis AO.

JCI Insight. 2016 Aug 4;1(12). pii: e88057.

8.

NFAT restricts osteochondroma formation from entheseal progenitors.

Ge X, Tsang K, He L, Garcia RA, Ermann J, Mizoguchi F, Zhang M, Zhou B, Zhou B, Aliprantis AO.

JCI Insight. 2016 Apr;1(4):e86254.

9.

Editorial: Of Mice and Mice: Understanding Conflicting Murine Experimental Data.

Ermann J.

Arthritis Rheumatol. 2016 Aug;68(8):1801-4. doi: 10.1002/art.39709. No abstract available.

10.

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L.

Arthritis Rheumatol. 2016 Feb;68(2):282-98. doi: 10.1002/art.39298. Epub 2015 Sep 24.

11.

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, Van Den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):151-66. doi: 10.1002/acr.22708. Epub 2015 Sep 24.

12.

XBP1-Independent UPR Pathways Suppress C/EBP-β Mediated Chondrocyte Differentiation in ER-Stress Related Skeletal Disease.

Cameron TL, Bell KM, Gresshoff IL, Sampurno L, Mullan L, Ermann J, Glimcher LH, Boot-Handford RP, Bateman JF.

PLoS Genet. 2015 Sep 15;11(9):e1005505. doi: 10.1371/journal.pgen.1005505. eCollection 2015 Sep.

13.

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.

Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao B, Korzenik JR, Glickman JN, Vemula PK, Glimcher LH, Traverso G, Langer R, Karp JM.

Sci Transl Med. 2015 Aug 12;7(300):300ra128. doi: 10.1126/scitranslmed.aaa5657.

14.

Immune cell profiling to guide therapeutic decisions in rheumatic diseases.

Ermann J, Rao DA, Teslovich NC, Brenner MB, Raychaudhuri S.

Nat Rev Rheumatol. 2015 Sep;11(9):541-51. doi: 10.1038/nrrheum.2015.71. Epub 2015 Jun 2. Review.

15.

The intestinal microbiome and skeletal fitness: Connecting bugs and bones.

Charles JF, Ermann J, Aliprantis AO.

Clin Immunol. 2015 Aug;159(2):163-9. doi: 10.1016/j.clim.2015.03.019. Epub 2015 Apr 1. Review.

16.

Cartilage-specific ablation of XBP1 signaling in mouse results in a chondrodysplasia characterized by reduced chondrocyte proliferation and delayed cartilage maturation and mineralization.

Cameron TL, Gresshoff IL, Bell KM, Piróg KA, Sampurno L, Hartley CL, Sanford EM, Wilson R, Ermann J, Boot-Handford RP, Glimcher LH, Briggs MD, Bateman JF.

Osteoarthritis Cartilage. 2015 Apr;23(4):661-70. doi: 10.1016/j.joca.2015.01.001. Epub 2015 Jan 17.

17.

Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice.

Ermann J, Staton T, Glickman JN, de Waal Malefyt R, Glimcher LH.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2559-66. doi: 10.1073/pnas.1408540111. Epub 2014 Jun 9.

18.

After GWAS: mice to the rescue?

Ermann J, Glimcher LH.

Curr Opin Immunol. 2012 Oct;24(5):564-70. doi: 10.1016/j.coi.2012.09.005. Epub 2012 Sep 29. Review.

19.

Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus.

Ermann J, Garrett WS, Kuchroo J, Rourida K, Glickman JN, Bleich A, Glimcher LH.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7137-41. doi: 10.1073/pnas.1104234108. Epub 2011 Apr 11.

20.

The biology behind the new therapies for SLE.

Ermann J, Bermas BL.

Int J Clin Pract. 2007 Dec;61(12):2113-9. Review.

PMID:
17997810
21.

Naive and memory T cells induce different types of graft-versus-host disease.

Dutt S, Tseng D, Ermann J, George TI, Liu YP, Davis CR, Fathman CG, Strober S.

J Immunol. 2007 Nov 15;179(10):6547-54.

22.

Development of active tuberculosis following initiation of infliximab despite appropriate prophylaxis.

Raychaudhuri S, Shmerling R, Ermann J, Helfgott S.

Rheumatology (Oxford). 2007 May;46(5):887-8. Epub 2007 Mar 15. No abstract available.

23.

L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.

Dutt S, Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S.

Blood. 2005 Dec 1;106(12):4009-15. Epub 2005 Aug 16.

24.

CD4+CD25+ regulatory T cells in hematopoietic stem cell transplantation.

Hoffmann P, Ermann J, Edinger M.

Curr Top Microbiol Immunol. 2005;293:265-85. Review.

PMID:
15981484
25.

Protein microarrays for multiplex analysis of signal transduction pathways.

Chan SM, Ermann J, Su L, Fathman CG, Utz PJ.

Nat Med. 2004 Dec;10(12):1390-6. Epub 2004 Nov 21.

PMID:
15558056
26.

Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, Negrin RS, Fathman CG, Strober S.

Blood. 2005 Mar 1;105(5):2220-6. Epub 2004 Nov 16.

27.

Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene.

Su L, Creusot RJ, Gallo EM, Chan SM, Utz PJ, Fathman CG, Ermann J.

J Immunol. 2004 Oct 15;173(8):4994-5001.

28.

Scratching the (T cell) surface.

Ermann J, Chung CD, Fathman CG.

Genome Biol. 2003;5(1):202. Epub 2003 Dec 11. Review.

29.

Costimulatory signals controlling regulatory T cells.

Ermann J, Fathman CG.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15292-3. Epub 2003 Dec 15. No abstract available.

30.

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS.

Nat Med. 2003 Sep;9(9):1144-50. Epub 2003 Aug 17.

PMID:
12925844
31.

Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4.

Tarner IH, Nakajima A, Seroogy CM, Ermann J, Levicnik A, Contag CH, Fathman CG.

Clin Immunol. 2002 Dec;105(3):304-14.

PMID:
12498812
32.
33.
34.

CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.

Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K.

J Immunol. 2001 Oct 15;167(8):4271-5.

35.

Autoimmune diseases: genes, bugs and failed regulation.

Ermann J, Fathman CG.

Nat Immunol. 2001 Sep;2(9):759-61. No abstract available.

PMID:
11526377
36.

A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses.

Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F.

J Immunol Methods. 2000 Dec 1;246(1-2):37-50.

PMID:
11121545
37.

Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis.

Schädlich H, Ermann J, Biskop M, Falk W, Sperling F, Jüngel A, Lehmann J, Emmrich F, Sack U.

Ann Rheum Dis. 1999 Jul;58(7):428-34.

39.

Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice.

Sack U, Kuhn H, Ermann J, Kinne RW, Vogt S, Jungmichel D, Emmrich F.

J Rheumatol. 1994 Jan;21(1):10-6.

PMID:
8151561

Supplemental Content

Loading ...
Support Center